Compare Abbott India with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PFIZER - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PFIZER ABBOTT INDIA/
PFIZER
 
P/E (TTM) x 48.1 42.2 114.2% View Chart
P/BV x 15.6 7.0 222.2% View Chart
Dividend Yield % 0.4 0.5 90.5%  

Financials

 ABBOTT INDIA   PFIZER
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
PFIZER
Mar-19
ABBOTT INDIA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs8,8343,840 230.1%   
Low Rs5,4582,080 262.4%   
Sales per share (Unadj.) Rs1,731.1455.0 380.5%  
Earnings per share (Unadj.) Rs211.993.8 226.0%  
Cash flow per share (Unadj.) Rs219.9109.4 201.0%  
Dividends per share (Unadj.) Rs65.0022.50 288.9%  
Dividend yield (eoy) %0.90.8 119.7%  
Book value per share (Unadj.) Rs945.2658.2 143.6%  
Shares outstanding (eoy) m21.2545.75 46.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.16.5 63.4%   
Avg P/E ratio x33.731.6 106.8%  
P/CF ratio (eoy) x32.527.1 120.1%  
Price / Book Value ratio x7.64.5 168.1%  
Dividend payout %30.724.0 127.8%   
Avg Mkt Cap Rs m151,848135,420 112.1%   
No. of employees `0003.52.6 132.5%   
Total wages/salary Rs m4,3563,238 134.5%   
Avg. sales/employee Rs Th10,555.57,911.4 133.4%   
Avg. wages/employee Rs Th1,249.91,230.9 101.5%   
Avg. net profit/employee Rs Th1,292.21,630.7 79.2%   
INCOME DATA
Net Sales Rs m36,78620,815 176.7%  
Other income Rs m1,1331,674 67.7%   
Total revenues Rs m37,91922,489 168.6%   
Gross profit Rs m6,0475,712 105.9%  
Depreciation Rs m169714 23.7%   
Interest Rs m2373 30.9%   
Profit before tax Rs m6,9896,599 105.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4852,309 107.6%   
Profit after tax Rs m4,5034,291 105.0%  
Gross profit margin %16.427.4 59.9%  
Effective tax rate %35.635.0 101.7%   
Net profit margin %12.220.6 59.4%  
BALANCE SHEET DATA
Current assets Rs m27,61027,167 101.6%   
Current liabilities Rs m8,5698,917 96.1%   
Net working cap to sales %51.887.7 59.0%  
Current ratio x3.23.0 105.8%  
Inventory Days Days6068 88.8%  
Debtors Days Days2730 91.0%  
Net fixed assets Rs m1,0578,862 11.9%   
Share capital Rs m213458 46.4%   
"Free" reserves Rs m19,87329,656 67.0%   
Net worth Rs m20,08630,113 66.7%   
Long term debt Rs m025 0.0%   
Total assets Rs m29,40939,400 74.6%  
Interest coverage x311.691.5 340.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.5 236.8%   
Return on assets %15.411.1 139.0%  
Return on equity %22.414.2 157.4%  
Return on capital %34.922.1 157.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m369428 86.1%   
Fx outflow Rs m4,918786 625.4%   
Net fx Rs m-4,549-358 1,270.4%   
CASH FLOW
From Operations Rs m4,991978 510.3%  
From Investments Rs m-2,570351 -731.8%  
From Financial Activity Rs m-1,428-1,099 130.0%  
Net Cashflow Rs m993231 430.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 63.9 117.4%  
Indian inst/Mut Fund % 7.9 7.5 105.3%  
FIIs % 0.1 4.9 2.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 23.7 72.2%  
Shareholders   18,270 85,207 21.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   UNICHEM LAB  AUROBINDO PHARMA  STERLING BIOTECH  GLENMARK PHARMA  VENUS REMEDIES  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Open Higher; JSW Steel & Tata Steel Top Gainers(09:30 am)

Asian share markets edged higher today as investors shrugged off concerns that stocks may have rallied too far too fast in the past year.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Mar 3, 2021 11:46 AM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS